• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阵发性夜间血红蛋白尿粒细胞中糖基磷脂酰肌醇锚合成缺陷。

Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes.

作者信息

Mahoney J F, Urakaze M, Hall S, DeGasperi R, Chang H M, Sugiyama E, Warren C D, Borowitz M, Nicholson-Weller A, Rosse W F

机构信息

Department of Medicine, Duke University, Durham, NC.

出版信息

Blood. 1992 Mar 15;79(6):1400-3.

PMID:1372185
Abstract

To investigate the biosynthesis of the glycosylphosphatidylinositol (GPI) anchor in the granulocytes of paroxysmal nocturnal hemoglobinuria (PNH), the glycolipids of granulocytes from PNH patients and normal volunteers were biosynthetically labeled with [3H]mannose in the presence of tunicamycin. Extracted glycolipids were examined by thin-layer chromatography and compared with known biosynthetic intermediates. Normal granulocytes consistently showed [3H]mannose incorporation into the complete GPI core, several GPI biosynthetic intermediates, and dolichol phosphate mannose (DPM). The granulocytes of 10 patients with PNH that had no expression of CD55 and CD59 on greater than 95% of the cells were able to incorporate [3H]mannose into DPM, but were not able to incorporate detectable amounts into the complete GPI core. THus, PNH granulocytes do not synthesize detectable amounts of the complete GPI core and this defect likely accounts for the absence of GPI-linked membrane proteins on hematopoietic cells in this syndrome.

摘要

为研究阵发性睡眠性血红蛋白尿(PNH)患者粒细胞中糖基磷脂酰肌醇(GPI)锚的生物合成,在衣霉素存在的情况下,用[3H]甘露糖对PNH患者和正常志愿者的粒细胞糖脂进行生物合成标记。提取的糖脂通过薄层色谱法进行检测,并与已知的生物合成中间体进行比较。正常粒细胞始终显示[3H]甘露糖掺入完整的GPI核心、几种GPI生物合成中间体和磷酸多萜醇甘露糖(DPM)中。10例PNH患者的粒细胞中,超过95%的细胞不表达CD55和CD59,这些粒细胞能够将[3H]甘露糖掺入DPM,但无法将可检测量的[3H]甘露糖掺入完整的GPI核心。因此,PNH粒细胞无法合成可检测量的完整GPI核心,这种缺陷可能是该综合征造血细胞上缺乏GPI连接膜蛋白的原因。

相似文献

1
Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes.阵发性夜间血红蛋白尿粒细胞中糖基磷脂酰肌醇锚合成缺陷。
Blood. 1992 Mar 15;79(6):1400-3.
2
Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells.正常细胞而非阵发性夜间血红蛋白尿细胞中甘露糖基葡糖胺基肌醇磷脂的合成。
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6025-9. doi: 10.1073/pnas.89.13.6025.
3
Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step.阵发性夜间血红蛋白尿中的糖基磷脂酰肌醇锚合成:早期步骤中的部分或完全缺陷。
Blood. 1994 Feb 1;83(3):816-21.
4
Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.人FcγRIIIPMN(CD16)在阵发性夜间血红蛋白尿中的优先表达。糖基磷脂酰肌醇连接蛋白的不一致表达。
J Clin Invest. 1991 Jan;87(1):58-67. doi: 10.1172/JCI115001.
5
Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.通过流式细胞术分析糖基磷脂酰肌醇锚定蛋白以评估阵发性夜间血红蛋白尿克隆大小。
Cytometry. 2000 Aug 15;42(4):234-8. doi: 10.1002/1097-0320(20000815)42:4<234::aid-cyto3>3.0.co;2-6.
6
Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.阵发性夜间血红蛋白尿患者红细胞中糖基磷脂酰肌醇(GPI)连接蛋白缺乏的两种不同模式。
Br J Haematol. 1992 Mar;80(3):399-405. doi: 10.1111/j.1365-2141.1992.tb08151.x.
7
Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿症患者克隆细胞系中糖基磷脂酰肌醇锚生物合成过程中N-乙酰葡糖胺掺入的特异性缺陷。
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5272-6. doi: 10.1073/pnas.90.11.5272.
8
Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).糖基磷脂酰肌醇(GPI)锚定膜蛋白在阵发性夜间血红蛋白尿(PNH)临床病理生理学中的作用
Fukushima J Med Sci. 1995 Jun;41(1):1-13.
9
Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.阵发性睡眠性血红蛋白尿/再生障碍性贫血中造血功能受损与糖基磷脂酰肌醇锚定蛋白缺陷克隆中的选择性增殖缺陷无关。
Blood. 1997 Feb 15;89(4):1173-81.
10
Mechanism of paroxysmal nocturnal hemoglobinuria clonal dominance: possible roles of different apoptosis and CD8+ lymphocytes in the selection of paroxysmal nocturnal hemoglobinuria clones.阵发性睡眠性血红蛋白尿克隆优势的机制:不同凋亡及CD8 + 淋巴细胞在阵发性睡眠性血红蛋白尿克隆选择中的可能作用
Hematol Oncol Stem Cell Ther. 2012;5(3):138-45. doi: 10.5144/1658-3876.2012.138.

引用本文的文献

1
Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors.靶向补体途径优化 PNH 治疗:培塞利珠单抗及其他已获批的补体抑制剂
Int J Mol Sci. 2024 Aug 31;25(17):9477. doi: 10.3390/ijms25179477.
2
CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities.CD59 基因:通过计算相位在来自不同种族的 113 个人中计算出 22718 个核苷酸长度的 143 个单倍型。
Transfusion. 2024 Jul;64(7):1296-1305. doi: 10.1111/trf.17869. Epub 2024 May 30.
3
A novel homozygous PIGO mutation associated with severe infantile epileptic encephalopathy, profound developmental delay and psychomotor retardation: structural and 3D modelling investigations and genotype-phenotype correlation.
一种与严重婴儿癫痫性脑病、严重发育迟缓及精神运动发育迟缓相关的新型纯合 PIGO 突变:结构与 3D 建模研究及基因型-表型相关性。
Metab Brain Dis. 2023 Dec;38(8):2665-2678. doi: 10.1007/s11011-023-01276-6. Epub 2023 Sep 1.
4
The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target.阵发性睡眠性血红蛋白尿症中的补体替代途径:从发病机制到治疗靶点。
Immunol Rev. 2023 Jan;313(1):262-278. doi: 10.1111/imr.13137. Epub 2022 Sep 15.
5
How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.我们将如何治疗阵发性睡眠性血红蛋白尿症:深入未来。
Br J Haematol. 2022 Jan;196(2):288-303. doi: 10.1111/bjh.17753. Epub 2021 Aug 5.
6
Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.抗补体治疗阵发性睡眠性血红蛋白尿症:是否需要近端补体抑制?来自 EBMT 的 SAAWP 的立场文件。
Front Immunol. 2019 Jun 14;10:1157. doi: 10.3389/fimmu.2019.01157. eCollection 2019.
7
Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going.阵发性睡眠性血红蛋白尿症的抗补体治疗:我们的现状与未来走向
Transl Med UniSa. 2014 Feb 4;8:43-52. eCollection 2014 Jan.
8
Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.阵发性夜间血红蛋白尿:生物制剂时代的病理生理学、自然病史及治疗选择
Biologics. 2008 Jun;2(2):205-22. doi: 10.2147/btt.s1420.
9
Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.糖基磷脂酰肌醇锚定补体调节蛋白衰变加速因子(CD55)和CD59在人白血病细胞系中表面表达缺失的机制。
Biochem J. 1996 Mar 15;314 ( Pt 3)(Pt 3):969-76. doi: 10.1042/bj3140969.
10
Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿症患者来源的细胞系中,糖基磷脂酰肌醇锚生物合成的首个中间体N-乙酰葡糖胺基磷脂酰肌醇生物合成缺陷。
J Exp Med. 1993 Feb 1;177(2):517-21. doi: 10.1084/jem.177.2.517.